Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards. PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果